Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

JANXJANX
Showing 8 of 21 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in JANUX THERAPEUTICS INC

Yes. RA Capital Management holds 11,189,693 shares of JANX (Janux Therapeutics), worth $171.9M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RA Capital Management has held JANX since Q2 2021, across 21 quarterly 13F filings. JANX is 1.5% of RA Capital Management's reported 13F portfolio.

Current Value

$171.9M

Current Shares

11.2M

Total Value Change

-$244.5M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
11.2M
0.0%
$171.9M1.5%$15.36
0
2026-Q1
Unchanged
11.2M
0.0%
$155.5M1.6%$13.44
0
2025-Q4
Unchanged
11.2M
0.0%
$154.4M1.6%$13.83
0
2025-Q3
Unchanged
11.2M
0.0%
$273.5M3.4%$23.70
0
2025-Q2
Unchanged
11.2M
0.0%
$258.5M4.4%$23.15
0
2025-Q1
Increased
11.2M
+8.0%
$302.1M5.0%$29.10
65
2024-Q4
Increased
10.4M
+13.1%
$555M7.4%$52.50
69
2024-Q3
Unchanged
9.2M
0.0%
$416.4M4.8%$46.25
0

Other major holders of JANX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used